Papadopoulos EB - Search Results

1

The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.

Kosuri S, Adrianzen Herrera D, Scordo M, Shah GL, Cho C, Devlin SM, Maloy MA, Nieves J, Borrill T, Carlow DC, Avecilla ST, Meagher RC, O'Reilly RJ, Papadopoulos EB, Jakubowski AA, Koehne G, Gyurkocza B, Castro-Malaspina H, Shaffer BC, Tamari R, Giralt SA, Perales MA. Kosuri S, et al. Among authors: papadopoulos eb. Biol Blood Marrow Transplant. 2017 Nov;23(11):2004-2011. doi: 10.1016/j.bbmt.2017.07.012. Epub 2017 Jul 18. Biol Blood Marrow Transplant. 2017. PMID: 28733264 Free PMC article.

2

New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.

Collins NH, Carabasi MH, Bleau S, Jagiello C, Young JW, Castro-Malaspina H, Flomenberg N, Papadopoulos EB, Emanuel D, Gillio A, et al. Collins NH, et al. Among authors: papadopoulos eb. Prog Clin Biol Res. 1992;377:427-39. Prog Clin Biol Res. 1992. PMID: 1438441 No abstract available.

3

T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission.

Young JW, Papadopoulos EB, Cunningham I, Castro-Malaspina H, Flomenberg N, Carabasi MH, Gulati SC, Brochstein JA, Heller G, Black P, et al. Young JW, et al. Among authors: papadopoulos eb. Blood. 1992 Jun 15;79(12):3380-7. Blood. 1992. PMID: 1596577 Free article.

4

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs BH, Gillio AP, Kernan NA, et al. Mackinnon S, et al. Among authors: papadopoulos eb. Blood. 1995 Aug 15;86(4):1261-8. Blood. 1995. PMID: 7632930 Free article.

5

Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?

Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reilly RJ. Mackinnon S, et al. Among authors: papadopoulos eb. Bone Marrow Transplant. 1995 Apr;15(4):591-4. Bone Marrow Transplant. 1995. PMID: 7655386

6

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, et al. Papadopoulos EB, et al. N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703. N Engl J Med. 1994. PMID: 8093146 Free article.

7

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.

Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ. Lacerda JF, et al. Among authors: papadopoulos eb. J Exp Med. 1996 Mar 1;183(3):1215-28. doi: 10.1084/jem.183.3.1215. J Exp Med. 1996. PMID: 8642263 Free PMC article.

8

Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB. O'Reilly RJ, et al. Among authors: papadopoulos eb. Important Adv Oncol. 1996:149-66. Important Adv Oncol. 1996. PMID: 8791134 Review. No abstract available.

9

Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.

Michel G, Boulad F, Small TN, Black P, Heller G, Castro-Malaspina H, Childs BH, Gillio AP, Papadopoulos EB, Young JW, Kernan NA, O'Reilly RJ. Michel G, et al. Among authors: papadopoulos eb. Bone Marrow Transplant. 1997 Jul;20(2):107-12. doi: 10.1038/sj.bmt.1700857. Bone Marrow Transplant. 1997. PMID: 9244412

10

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L. O'Reilly RJ, et al. Immunol Rev. 1997 Jun;157:195-216. doi: 10.1111/j.1600-065x.1997.tb00983.x. Immunol Rev. 1997. PMID: 9255631 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters